Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Saeed Sheikh

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Vitamins and Hormones|April 28, 2004
TRAIL death receptors, Bcl-2 protein family, and endoplasmic reticulum calcium poolM Saeed Sheikh, Ying Huang
Recent Patents on Anti-Cancer Drug Discovery|August 1, 2022
Antibody-drug Conjugates for Breast Cancer TreatmentM Saeed Sheikh, Ying Huang
Cancers|September 13, 2025
Cell Death, Molecular Targeted Therapies, and Metabolic Reprogramming in EGFR-Mutant Lung CancerHimani Joshi, M Saeed Sheikh
Molecular and Cellular Pharmacology|April 24, 2023
Sacituzumab govitecan for hormone receptor-positive and triple-negative breast cancersSiem A Satti, M Saeed Sheikh
Molecular and Cellular Pharmacology|March 7, 2022
The emerging CDK4/6 inhibitor for breast cancer treatmentM Saeed Sheikh, Siem A Satti
Oncogene|December 24, 2003
Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cellsQin He, Ying Huang, M Saeed Sheikh
Oncogene|October 17, 2003
Cloning and characterization of a novel gene PDRG that is differentially regulated by p53 and ultraviolet radiationXiuquan Luo, Ying Huang, M Saeed Sheikh
Cell Death & Disease|July 19, 2020
ECRG2, a novel transcriptional target of p53, modulates cancer cell sensitivity to DNA damageHarsh Patel, M Saeed Sheikh, Ying Huang
Genes & Cancer|September 29, 2015
Regulation of p53 oligomerization by Ras superfamily protein RBEL1AKi Lui, M Saeed Sheikh, Ying Huang
Molecular and Cellular Pharmacology|June 2, 2010
Decision Making by p53: Life versus DeathLingyan Jiang, M Saeed Sheikh, Ying Huang
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Vitamins and Hormones|April 28, 2004
TRAIL death receptors, Bcl-2 protein family, and endoplasmic reticulum calcium poolM Saeed Sheikh, Ying Huang
Recent Patents on Anti-Cancer Drug Discovery|August 1, 2022
Antibody-drug Conjugates for Breast Cancer TreatmentM Saeed Sheikh, Ying Huang
Cancers|September 13, 2025
Cell Death, Molecular Targeted Therapies, and Metabolic Reprogramming in EGFR-Mutant Lung CancerHimani Joshi, M Saeed Sheikh
Molecular and Cellular Pharmacology|April 24, 2023
Sacituzumab govitecan for hormone receptor-positive and triple-negative breast cancersSiem A Satti, M Saeed Sheikh
Molecular and Cellular Pharmacology|March 7, 2022
The emerging CDK4/6 inhibitor for breast cancer treatmentM Saeed Sheikh, Siem A Satti
Oncogene|December 24, 2003
Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cellsQin He, Ying Huang, M Saeed Sheikh
Oncogene|October 17, 2003
Cloning and characterization of a novel gene PDRG that is differentially regulated by p53 and ultraviolet radiationXiuquan Luo, Ying Huang, M Saeed Sheikh
Cell Death & Disease|July 19, 2020
ECRG2, a novel transcriptional target of p53, modulates cancer cell sensitivity to DNA damageHarsh Patel, M Saeed Sheikh, Ying Huang
Genes & Cancer|September 29, 2015
Regulation of p53 oligomerization by Ras superfamily protein RBEL1AKi Lui, M Saeed Sheikh, Ying Huang
Molecular and Cellular Pharmacology|June 2, 2010
Decision Making by p53: Life versus DeathLingyan Jiang, M Saeed Sheikh, Ying Huang
Pageof 7